1. GENERAL INFORMATION
1.1 Trivitamix is a sterile solution containing 30,000ME Vitamin ‘A’, 40000ME vitamin D3 and 20 mg vitamin E in vegetable oil in 1 ml.
1.2 Trivitamix by its appearance is a clear oily liquid with yellow to light brown color having characteristic vegetable oil odor.
1.3 The drug is available in glass vials by 10, 20, 50, 100.0 and 200.0 ml.
1.4 The drug should be stored in dry place, protected from direct sunlight, away from children within the temperature range +5°C to +25°C. Shelf life is 2 years from date of manufacture, under specified storage conditions.
2. PHARMACOLOGICAL PROPERTIES
2.1. Trivitamix is a combination vitamin drug, where vitamin A (retinol palmitate and retinol acetate), D3 (cholecalciferol) and E (α-tocopherol acetate) are presented in physiologically sound ratios, having synergistic effect in the animal body, resulted in normalization of metabolism, increase of resistance to infectious diseases, improvement of fertility and promoting growth of young animals.
2.2. Vitamin A accelerates growth of organism and increases its resistance as well enhances protective function of epithelium and facilitated regeneration of epithelial tissue. It is closely related to the effects of sex hormones in the body. Due to lack of this vitamin in animals visual disturbances, xerophthalmia, poor vitality of newborn, catarrhal inflammation of the gastrointestinal tract mucous membranes and reproductive organs may be observed as well as loss of ability to reproduction.
2.3. Vitamin D3 regulates mineral metabolism in the body. During its lack in animals rickets or osteomalacia, tetanic convulsions and allotriophagy may be observed.
2.4. Due to lack of vitamin E in animal infertility, growth retardation, damage of central nervous system (encephalomalacia), degeneration of the liver and muscle tissue may be observed as well as metabolic imbalance of fats and carbohydrates.
3. DRUG USAGE PROCEDURE
3.1. Trivitamix is used against hypo-and avitaminosis in animals for treatment and prevention of xerophthalmia, rickets, osteomalacia. It is recommended to use during pregnancy, lactation, and in rehabilitation period after disease.
3.2. The drug is administered intramuscularly, subcutaneously or orally at the following doses (per animal):
|Growing horses, calves||1,5||3|
|Sheep and goats||1,0||2|
|Goose and turkey||-||1|
|Chickens||-||1 per three birds|
The drug is administered intramuscularly or subcutaneously once a week within a month. If required, you may repeat injections in a month. If parenteral administration is impossible, the drug shall be given orally, preferably in mixture with feed daily within 3-4 weeks. In order to increase effectiveness of the drug use in animal feeding rations should be balanced in calcium, phosphorus, magnesium and trace elements.
3.3. The drug does not have side effects in animal organism at therapeutic doses.
3.4. No contraindications have been established for the drug use.
3.5. Slaughter of animals for meat production and use of animal and bids products for food purposes after drug treatment shall be made without restrictions.
4. CLAIMS PROCEDURE
4.1. In case of complications after drug administration its use should be discontinued and reported to the Uzbek State Scientific and Veterinary Drugs Control Laboratory at: 700178, Tashkent, No.1a, A.Yunusov str.,Tel/Fax: 228-76-14, 229-30-47. E-mal: email@example.com. Simultaneously unpacked drug package should be sent to the laboratory address with the drug in quantity previously agreed with laboratory including detailed description of the nature of complaints regarding its inconsistency with these Instructions.